Drug class in one race
MAO-B drugs for Parkinson's Disease
3 tracked MAO-B drugs in the Parkinson's Disease race. The class explanation lives on the MAO-B page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
2 approved / phase 41 Phase 1
Head-to-head evidence: HNC364 vs Rasagiline (Azilect) · HNC364 vs Safinamide · Rasagiline (Azilect) vs Safinamide